The influence of hepatic transit on the ability of exogenous cholecystokinin-8-sulfate and -33-sulfate (CCK-8 and CCK-33, respectively) to stimulate gallbladder contraction and exocrine pancreatic secretion, as well as on the peripheral plasma concentration of each agent, was evaluated in five conscious dogs with pancreatic and gallbladder fistulas and complete portacaval transposition. The gallbladder pressure increments after portal administration of CCK-8 (0.125, 0.25, 0.50, and 1.0 microgram/kg per h for 5 min) were diminished by 36, 45, 39 and 25%, respectively, in comparison with those obtained with systemic administration of identical doses of CCK-8 (P less than 0.05). In a subsequent experiment, the integrated pancreatic juice volume, bicarbonate, and protein secretion were diminished by 22, 32, and 48%, respectively, during a 30-min infusion of CCK-8 (0.10 micrograms/kg per h) into the portal venous system, in comparison with the results obtained with systemic administration of CCK-8 (P less than 0.05). In contrast, the gallbladder pressure and pancreatic exocrine secretory responses to portal administration of CCK-33 did not differ significantly (P greater than 0.05) from the results obtained with systemic administration of CCK-33. Radioimmunoassay for CCK-8 in plasma showed that the integrated CCK-8 value during portal administration was significantly lower (P less than 0.05) than it was during systemic administration. The results for CCK-33, however, did not vary, whether it was given by a systemic or portal route (P greater than 0.05). Thus, the present study demonstrates that CCK-8 is partially inactivated by the liver whereas CCK-33 is not, which suggests that CCK-3 in the circulation may play a significant role in the physiologic regulation of the gallbladder and exocrine pancreas.
T Sakamoto, M Fujimura, J Newman, X G Zhu, G H Greeley Jr, J C Thompson
Title and authors | Publication | Year |
---|---|---|
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects
M Acalovschi |
World journal of gastroenterology : WJG | 2014 |
Ileal interposition attenuates the satiety responses evoked by cholecystokinin-8 and -33
SA Metcalf, MC Washington, TA Brown, CS Williams, AD Strader, AI Sayegh |
Peptides | 2011 |
The feeding responses evoked by cholecystokinin are mediated by vagus and splanchnic nerves
TA Brown, MC Washington, SA Metcalf, AI Sayegh |
Peptides | 2011 |
The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval
DM Lateef, MC Washington, AI Sayegh |
Peptides | 2011 |
Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complex
MS Cooper, JR Reeve, MO Abdalla, L Moyer, SJ Raboin, GM Green, AI Sayegh |
Brain Research | 2008 |
The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6
JF Rehfeld, JR Bundgaard, J Hannibal, X Zhu, C Norrbom, DF Steiner, L Friis-Hansen |
Endocrinology | 2007 |
Physiology of the Gastrointestinal Tract
DJ Drucker |
Physiology of the Gastrointestinal Tract | 2006 |
Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver
MG Ismair, B Stieger, V Cattori, B Hagenbuch, M Fried, PJ Meier, GA Kullak-Ublick |
Gastroenterology | 2001 |
Molecular Forms of Cholecystokinin in Human Bile in Patients with Obstructive Jaunice
A TAKAHASHI, S TANAKA, H YOSHIDA, S NAKAMATA, F NOZU, I NAKANO, K KITAMURA, T IMAMURA, A IKEGAMI, J NIIKAWA, K MITAMURA |
The Showa University Journal of Medical Sciences | 2000 |
Cholecystokinin in Acute Alcoholic and Biliary Pancreatitis
S Räty, J Sand, E Kemppainen, S Laine, I Nordback |
International Journal of Gastrointestinal Cancer | 2000 |
Cholecystokinin in the early course of acute post-ERCP pancreatitis
S Räty, J Sand, S Laine, A Harmoinen, I Nordback |
Journal of the American College of Surgeons | 1999 |
Gastric and gall bladder emptying of a mixed meal are not coordinated in liver cirrhosis--a simultaneous sonographic study
M Acalovschi, DL Dumitraşcu, I Csakany |
Gut | 1997 |
Prolonged intestinal afferent nerve discharge in response to cholecystokinin-58 compared to cholecystokinin-8 in rats
M Kreis |
Neuroscience Letters | 1997 |
Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide
K Beckh, A Dirks, I Koop, H Koop, G Adler |
Research in Experimental Medicine | 1997 |
Absorption of Orally Administered Enzymes
ML Gardner, KJ Steffens |
1995 | |
Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors
SP Povoski, W Zhou, DS Longnecker, RT Jensen, SA Mantey, RH Bell |
Gastroenterology | 1994 |
The Molecular Nature of Cholecystokinin in Plasma: An in vivo Immunosorption Study in Rabbits
JF Rehfeld |
Scandinavian Journal of Gastroenterology | 1994 |
Physiology and Pathophysiology of Gallbladder Motility
S Tierney, HA Pitt, KD Lillemoe |
Surgical Clinics of North America | 1993 |
Pancreatic trophism in experimental liver cirrhosis
I Nagy, F Hajnal, G Mohácsi, J Németh, Z Lászik, Á Pap |
International Journal of Gastrointestinal Cancer | 1993 |
Bile acids in human plasma interfere with cholecystokinin bioassay using dispersed pancreatic acini
K Miyasaka, A Funakoshi, M Matsumoto, R Nakamura, S Sakamoto, H Sakai, K Kitani |
Digestive Diseases and Sciences | 1991 |
Cholecystokinin and Glucose-Induced Insulinaemia in Dogs With and Without Pancreatic Acinar Atrophy
RH Meister, IH Berger, PO Schwille |
Clinical Chemistry and Laboratory Medicine | 1990 |
Cholecystokinin binding and degradation by isolated rat liver cells
MM Wolfe, M Bougoulias, JE McGuigan |
Regulatory Peptides | 1990 |
Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man
MC Jebbink, JB Jansen, AA Masclee, CB Lamers |
British Journal of Clinical Pharmacology | 1990 |
Pharmacokinetics and organ catabolism of cholecystokinin octapeptide in pigs
JC Cuber, C Bernard, T Gibard, JA Chayvialle |
Regulatory Peptides | 1989 |
Gastrointestinal Peptides
DW Green, G Gomez, GH Greeley |
Gastroenterology Clinics of North America | 1989 |
Cholecystokinin cleavage to cholecystokinin-octapeptide in vivo and in vitro: Accelerated cleavage in acute pancreatitis
CJ Springer, J Calam |
Gastroenterology | 1988 |
Plasma cholecystokinin-octapeptide like immunoreactivity in patients with hepatic cirrhosis
S Kanayama, S Himeno, Y Higashimoto, Y Yamasaki, T Kitani, S Tarui |
Life Sciences | 1987 |
A High Pressure Liquid Chromatography-Radioimmunoassay Method for Measurement of Cholecystokinin-8 and Cholecystokinin-33/39 in Plasma
EJ Draviam, GH Greeley, RD Beauchamp, JC Thompson |
Journal of Liquid Chromatography | 1987 |
The Biosynthesis of Regulatory Peptides
GJ Dockray |
American journal of respiratory and critical care medicine | 1987 |
Effect of synthetic trypsin inhibitor on plasma immunoreactive cholecystokinin in rats
S Kanayama, S Himeno, Y Yamasaki, Y Shinomura, T Kitani, S Tarui |
Gastroenterologia Japonica | 1987 |
Stand und Gegenstand chirurgischer Forschung
FW Eigler, HJ Peiper, FW Schildberg, J Witte, V Zumtobel |
1986 | |
Inactivation of cholecystokinin octapeptide by normal and cirrhotic liver in rats
Z Berger, Á Pap, I Ungi, V Varro |
International Journal of Gastrointestinal Cancer | 1986 |
Advances in Metabolic Disorders
G Aurbach, JT Potts |
Advances in Metabolic Disorders | 1964 |